Skip to Main Content

Paper Details

Chaperone protein P4HB predicts temozolomide response and prognosis in malignant glioma.
Oncol Lett
5
2022
Cancer, Cancer cells, Chaperone protein P4HB, MGMT, MGMT promoter, MGMTP4HB, MGMTP4HB tumours, O6-methylguanine, O6-methylguanine-DNA methyltransferase, O6-methylguanine-DNA methyltransferase (MGMT) promoter, P4HB, Patients, Prolyl, Prolyl 4-hydroxylase beta polypeptide, TMZ, glioma, gliomas, high-grade gliomas, malignant glioma, patients, temozolomide, tumour, unfolded protein
Author NameAffiliation
Gilberto Ka Kit LeungSchool of Clinical Medicine, The University of Hong Kong, Queen Mary Hospital
Gilberto Ka Kit LeungSchool of Clinical Medicine, The University of Hong Kong, Queen Mary Hospital
  • 1 - 2

Datasets

Release 1.2